A Human Depression Circuit Derived From Focal Brain Lesions.


Journal

Biological psychiatry
ISSN: 1873-2402
Titre abrégé: Biol Psychiatry
Pays: United States
ID NLM: 0213264

Informations de publication

Date de publication:
15 11 2019
Historique:
received: 15 02 2019
revised: 24 07 2019
accepted: 25 07 2019
pubmed: 29 9 2019
medline: 7 10 2020
entrez: 29 9 2019
Statut: ppublish

Résumé

Focal brain lesions can lend insight into the causal neuroanatomical substrate of depression in the human brain. However, studies of lesion location have led to inconsistent results. Five independent datasets with different lesion etiologies and measures of postlesion depression were collated (N = 461). Each 3-dimensional lesion location was mapped to a common brain atlas. We used voxel lesion symptom mapping to test for associations between depression and lesion locations. Next, we computed the network of regions functionally connected to each lesion location using a large normative connectome dataset (N = 1000). We used these lesion network maps to test for associations between depression and connected brain circuits. Reproducibility was assessed using a rigorous leave-one-dataset-out validation. Finally, we tested whether lesion locations associated with depression fell within the same circuit as brain stimulation sites that were effective for improving poststroke depression. Lesion locations associated with depression were highly heterogeneous, and no single brain region was consistently implicated. However, these same lesion locations mapped to a connected brain circuit, centered on the left dorsolateral prefrontal cortex. Results were robust to leave-one-dataset-out cross-validation. Finally, our depression circuit derived from brain lesions aligned with brain stimulation sites that were effective for improving poststroke depression. Lesion locations associated with depression fail to map to a specific brain region but do map to a specific brain circuit. This circuit may have prognostic utility in identifying patients at risk for poststroke depression and therapeutic utility in refining brain stimulation targets.

Sections du résumé

BACKGROUND
Focal brain lesions can lend insight into the causal neuroanatomical substrate of depression in the human brain. However, studies of lesion location have led to inconsistent results.
METHODS
Five independent datasets with different lesion etiologies and measures of postlesion depression were collated (N = 461). Each 3-dimensional lesion location was mapped to a common brain atlas. We used voxel lesion symptom mapping to test for associations between depression and lesion locations. Next, we computed the network of regions functionally connected to each lesion location using a large normative connectome dataset (N = 1000). We used these lesion network maps to test for associations between depression and connected brain circuits. Reproducibility was assessed using a rigorous leave-one-dataset-out validation. Finally, we tested whether lesion locations associated with depression fell within the same circuit as brain stimulation sites that were effective for improving poststroke depression.
RESULTS
Lesion locations associated with depression were highly heterogeneous, and no single brain region was consistently implicated. However, these same lesion locations mapped to a connected brain circuit, centered on the left dorsolateral prefrontal cortex. Results were robust to leave-one-dataset-out cross-validation. Finally, our depression circuit derived from brain lesions aligned with brain stimulation sites that were effective for improving poststroke depression.
CONCLUSIONS
Lesion locations associated with depression fail to map to a specific brain region but do map to a specific brain circuit. This circuit may have prognostic utility in identifying patients at risk for poststroke depression and therapeutic utility in refining brain stimulation targets.

Identifiants

pubmed: 31561861
pii: S0006-3223(19)31557-4
doi: 10.1016/j.biopsych.2019.07.023
pmc: PMC7531583
mid: NIHMS1543275
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

749-758

Subventions

Organisme : NINDS NIH HHS
ID : K23 NS083741
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH113929
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Références

Brain Stimul. 2017 Mar - Apr;10(2):270-274
pubmed: 27839722
Neuroimage. 2014 May 15;92:381-97
pubmed: 24530839
J Cogn Neurosci. 2007 Jul;19(7):1081-8
pubmed: 17583985
Neuron. 2007 Mar 15;53(6):905-18
pubmed: 17359924
Psychooncology. 2002 May-Jun;11(3):230-8
pubmed: 12112483
Neurocrit Care. 2016 Jun;24(3):397-403
pubmed: 26503511
J Geriatr Psychiatry Neurol. 1991 Jul-Sep;4(3):173-8
pubmed: 1953971
Neurology. 2016 Jun 7;86(23):2187-95
pubmed: 27170566
Biol Psychiatry. 2018 Jul 1;84(1):28-37
pubmed: 29274805
Brain. 1984 Mar;107 ( Pt 1):81-93
pubmed: 6697163
Sci Data. 2015 Jul 07;2:150031
pubmed: 26175908
Transl Psychiatry. 2018 Mar 9;7(11):4
pubmed: 29520018
Brain. 2017 Feb;140(2):497-507
pubmed: 28082298
Psychiatry Res. 2006 Nov 22;148(1):33-45
pubmed: 17029760
Am J Phys Med Rehabil. 2010 May;89(5):362-8
pubmed: 20407301
Exp Brain Res. 1996;107(3):479-85
pubmed: 8821387
Ann Neurol. 2018 Jul;84(1):153-157
pubmed: 30014594
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
Qual Life Res. 2012 Apr;21(3):475-86
pubmed: 21874314
Biol Psychiatry. 2000 Nov 15;48(10):962-70
pubmed: 11082469
Neuroimage. 2017 Aug 15;157:34-44
pubmed: 28572060
J Neurol. 2015 Jan;262(1):81-90
pubmed: 25308633
Ann Neurol. 2017 Jul;82(1):67-78
pubmed: 28586141
Ann Neurol. 2010 Mar;67(3):365-75
pubmed: 20373348
Proc Natl Acad Sci U S A. 2018 Oct 16;115(42):10792-10797
pubmed: 30275309
Brain. 2018 Aug 1;141(8):2445-2456
pubmed: 29982424
J Stroke Cerebrovasc Dis. 2019 May;28(5):1236-1242
pubmed: 30718064
Am J Psychiatry. 1999 May;156(5):675-82
pubmed: 10327898
Lancet. 1996 Jul 27;348(9022):233-7
pubmed: 8684201
J Affect Disord. 2016 Dec;206:280-286
pubmed: 27639862
Biol Psychiatry. 2001 Aug 1;50(3):171-8
pubmed: 11513815
N Engl J Med. 2018 Dec 6;379(23):2237-2245
pubmed: 30575457
Arch Intern Med. 1998 May 25;158(10):1133-8
pubmed: 9605786
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
JAMA Psychiatry. 2015 Jun;72(6):603-11
pubmed: 25785575
Top Stroke Rehabil. 2018 Jan;25(1):61-67
pubmed: 28982298
Int J Stroke. 2014 Dec;9(8):1026-36
pubmed: 25156411
Neuroimage. 2013 Feb 1;66:151-60
pubmed: 23142067
Neuron. 2005 Mar 3;45(5):651-60
pubmed: 15748841
Cerebrovasc Dis. 2009;28(6):551-7
pubmed: 19844094
Kaohsiung J Med Sci. 2004 Aug;20(8):372-80
pubmed: 15473648
Neuron. 2015 Mar 4;85(5):927-41
pubmed: 25741721
J Neurosci. 2010 Mar 17;30(11):3964-72
pubmed: 20237267
J Natl Cancer Inst. 2011 Jan 5;103(1):61-76
pubmed: 21106962
Proc Natl Acad Sci U S A. 2016 Jul 26;113(30):E4367-76
pubmed: 27402738
Lancet. 2000 Jul 8;356(9224):122-6
pubmed: 10963248
Adv Physiol Educ. 2017 Sep 1;41(3):449-453
pubmed: 28743689
Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):7900-5
pubmed: 27357684
Proc Natl Acad Sci U S A. 2018 Jan 16;115(3):601-606
pubmed: 29255017
Brain Behav. 2017 Aug 30;7(10):e00788
pubmed: 29075559
J Neuropsychiatry Clin Neurosci. 2003 Fall;15(4):422-30
pubmed: 14627768
PLoS One. 2015 Apr 02;10(3):e0121945
pubmed: 25835001
Br J Psychiatry. 2013 Jan;202(1):14-21
pubmed: 23284148
Neurology. 2016 Dec 6;87(23):2427-2434
pubmed: 27815400
Stroke. 1982 Sep-Oct;13(5):635-41
pubmed: 7123596
Int J Neurosci. 1987 Feb;32(3-4):799-810
pubmed: 3596923
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
BMJ Open. 2014 Jul 07;4(7):e004948
pubmed: 25001395
J Neurosci. 2008 Nov 19;28(47):12341-8
pubmed: 19020027
Neuroimage. 2014 Apr 1;89:216-25
pubmed: 24345389
J Neurophysiol. 2011 Sep;106(3):1125-65
pubmed: 21653723
Biol Psychiatry. 2004 Feb 15;55(4):398-405
pubmed: 14960293
Brain. 2014 Sep;137(Pt 9):2408-22
pubmed: 24871646
Brain. 2015 Oct;138(Pt 10):3061-75
pubmed: 26264514
Neuroimage. 2018 Jan 15;165:180-189
pubmed: 29042216

Auteurs

Jaya L Padmanabhan (JL)

Department of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Berenson-Allen Center for Non-Invasive Brain Stimulation, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Division of Cognitive Neurology, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. Electronic address: jayapad@gmail.com.

Danielle Cooke (D)

Berenson-Allen Center for Non-Invasive Brain Stimulation, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

Juho Joutsa (J)

Berenson-Allen Center for Non-Invasive Brain Stimulation, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Department of Neurology, University of Turku, Turku, Finland; Division of Clinical Neurosciences, Turku University Hospital, Turku, Finland.

Shan H Siddiqi (SH)

Department of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Berenson-Allen Center for Non-Invasive Brain Stimulation, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Division of Cognitive Neurology, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Division of Neurotherapeutics, McLean Hospital, Harvard Medical School, Boston, Massachusetts; Center for Neuroscience and Regenerative Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland.

Michael Ferguson (M)

Berenson-Allen Center for Non-Invasive Brain Stimulation, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

R Ryan Darby (RR)

Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee.

Louis Soussand (L)

Berenson-Allen Center for Non-Invasive Brain Stimulation, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

Andreas Horn (A)

Movement Disorders and Neuromodulation Unit, Department of Neurology, Charité-University Medicine Berlin, Berlin, Germany.

Na Young Kim (NY)

Berenson-Allen Center for Non-Invasive Brain Stimulation, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Department and Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.

Joel L Voss (JL)

Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Andrew M Naidech (AM)

Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Amy Brodtmann (A)

Florey Institute of Neuroscience and Mental Health, Melbourne, Victoria, Australia; Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, Victoria, Australia.

Natalia Egorova (N)

Florey Institute of Neuroscience and Mental Health, Melbourne, Victoria, Australia; Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, Victoria, Australia.

Sophia Gozzi (S)

School of Psychological Sciences, Department of Medicine, Monash University, Melbourne, Victoria, Australia; Stroke and Aging Research Group, School of Clinical Sciences, Department of Medicine, Monash University and Stroke Unit, Monash Medical Centre, Melbourne, Victoria, Australia.

Thanh G Phan (TG)

School of Psychological Sciences, Department of Medicine, Monash University, Melbourne, Victoria, Australia; Stroke and Aging Research Group, School of Clinical Sciences, Department of Medicine, Monash University and Stroke Unit, Monash Medical Centre, Melbourne, Victoria, Australia.

Maurizio Corbetta (M)

Department of Neuroscience, University of Padova and Padova Neuroscience Center, Padova, Italy; Departments of Neurology, Radiology, Bioengineering, and Neuroscience, Washington University School of Medicine, Saint Louis, Missouri.

Jordan Grafman (J)

Psychiatry and Behavioral Sciences and Cognitive Neurology/Alzheimer's Disease Research Center, Feinberg School of Medicine and Department of Psychology, Northwestern University, Chicago, Illinois; Shirley Ryan AbilityLab, Chicago, Illinois.

Michael D Fox (MD)

Berenson-Allen Center for Non-Invasive Brain Stimulation, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Division of Cognitive Neurology, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. Electronic address: foxmdphd@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH